HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel molecular mechanisms underlying the ameliorative effect of N-acetyl-L-cysteine against ϒ-radiation-induced premature ovarian failure in rats.

Abstract
Radiotherapy represents a critical component in cancer treatment. However, premature ovarian failure (POF) is a major hurdle of deleterious off-target effects in young females, which, therefore, call for an effective radioprotective agent. The present study aimed to explore the molecular mechanism underlying the protective effects of N-acetyl-L-cysteine (NAC) against γ-radiation-provoked POF. Immature female Sprague-Dawley rats were orally-administered NAC (50 mg/kg) and were exposed to a single whole-body dose of 3.2 Gy ϒ-radiation. NAC administration remarkably reversed abnormal serum estradiol and anti-Müllerian hormone levels by 73% and 40%, respectively while ameliorating the histopathological and ultrastructural alterations-triggered by γ-radiation. Mechanistically, NAC alleviated radiation-induced oxidative damage through significantly increased glutathione peroxidase activity by 102% alongside with decreasing NADPH oxidase subunits (p22 and NOX4) gene expressions by 48% and 38%, respectively compared to the irradiated untreated group. Moreover, NAC administration achieved its therapeutic effect by inhibiting ovarian apoptosis-induced by radiation through downregulating p53 and Bax levels by 33% and 16%, respectively while increasing the Bcl-2 mRNA expression by 135%. Hence, the Bax/Bcl2 ratio and cytochrome c expression were subsequently reduced leading to decreased caspase 3 activity by 43%. Importantly, the anti-apoptotic property of NAC could be attributed to inactivation of MAPK signaling molecules; p38 and JNK, and enhancement of the ovarian vascular endothelial growth factor (VEGF) expression. Taken together, our results suggest that NAC can inhibit radiotherapy-induced POF while preserving ovarian function and structure through upregulating VEGF expression and suppressing NOX4/MAPK/p53 apoptotic signaling.
AuthorsEman M Mantawy, Riham S Said, Dina H Kassem, Amal Kamal Abdel-Aziz, Amira Mohamed Badr
JournalEcotoxicology and environmental safety (Ecotoxicol Environ Saf) Vol. 206 Pg. 111190 (Dec 15 2020) ISSN: 1090-2414 [Electronic] Netherlands
PMID32871518 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • Apoptosis Regulatory Proteins
  • Radiation-Protective Agents
  • Vascular Endothelial Growth Factor A
  • NADPH Oxidase 4
  • Nox4 protein, rat
  • Acetylcysteine
Topics
  • Acetylcysteine (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Apoptosis Regulatory Proteins (metabolism)
  • Disease Models, Animal
  • Female
  • Gamma Rays (adverse effects)
  • Humans
  • MAP Kinase Signaling System (drug effects, radiation effects)
  • NADPH Oxidase 4 (metabolism)
  • Ovary (drug effects, metabolism, radiation effects, ultrastructure)
  • Oxidative Stress (drug effects, radiation effects)
  • Primary Ovarian Insufficiency (etiology, metabolism, pathology, prevention & control)
  • Radiation-Protective Agents (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: